Success Story: NIW Petition Approved for a Molecular Biology Expert from Albania with Our Tailored Strategy and Swift Filing

 

Client’s Testimonial:

“Thank you for your work on the EB2 NIW approval.”


On February 10th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Molecular Biology Expert in the Field of Molecular Biology (Approval Notice).


General Field: Molecular Biology

Position at the Time of Case Filing: Molecular Biology Expert

Country of Origin: Albania

State of Residence at the Time of Filing: California

Approval Notice Date: February 10th, 2025

Processing Time: 2 months, 4 days (Premium Processing Requested)


Case Summary:

At North America Immigration Law Group, we take immense pride in helping researchers with outstanding potential navigate their U.S. immigration journey. We are thrilled to share the success story of a talented scientist from Albania who recently secured I-140 NIW (National Interest Waiver) approval within just 2 months and 4 days of filing, thanks to our careful planning and the benefits of Premium Processing.

    - Client Background and Field

Our client holds a Ph.D. in biological sciences and currently works as a scientist in a pharma company. Specializing in molecular biology, her research focuses on identifying drug targets and their mechanisms of action in complex biological samples. Her work plays a crucial role in advancing clinical studies on diseases such as cancer, metabolic disorders, and neurodegenerative conditions.

    - Petition Strategy and Highlights

Upon receiving her case, our team carefully reviewed her academic and professional credentials. We crafted a personalized NIW petition that emphasized her significant contributions to the advancement of critical and emerging technologies recognized by national authorities.

To showcase her strong qualifications, we highlighted:

  • 5 peer-reviewed journal articles (including 2 first-authored) and 14 abstracts (with 7 first-authored) published in top journals.
  • 46 total citations to her research, according to Google Scholar, demonstrating her work's recognition and influence across the scientific community.
  • At least 4 instances of invited peer review service for prestigious scientific journals, affirming her status as a trusted expert in her field.
  • Her study has received funding from the NIGMS. This funding supports projects that advance biological research. Therefore, her research integrates proteogenomic approaches to elucidate the relationship between genetic mutations and protein functions in breast cancer, thereby enhancing the understanding of disease mechanisms and informing the development of targeted therapies.
Moreover, her research record includes work that ranks among the top 20% most-cited papers in the field of Biology & Biochemistry for its publication year — a testament to her novel and impactful contributions.

    - Establishing National Importance

We thoroughly illustrated how our client’s research advances the U.S. interest by:

  • Improving public health through better early detection and targeted treatment strategies for major diseases.
  • Contributing to the development of personalized medicine approaches.
  • Reducing the economic burden associated with diseases like cancer and Alzheimer’s disease.
Our arguments were bolstered with strong recommendation letters from leading independent experts, documentation of prestigious research funding, and the client's proven ability to contribute to federally recognized critical technology sectors.

    - Case Outcome

Thanks to our strategic presentation of her achievements and the robust evidence package, her I-140 NIW petition was approved without a Request for Evidence (RFE). This milestone was achieved just 2 months and 4 days after filing with Premium Processing, marking another proud success for our team.

We are honored that she entrusted us with her immigration journey and are excited to see her continue making groundbreaking advancements in molecular biology that benefit the United States and the global community.